Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura H Tang

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Human Pathology|March 18, 2008
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significanceJinru Shia, David S Klimstra, James R Nitzkorski, et al.
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Nature Communications|March 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.
Annals of Surgery|November 30, 2021
Distinct Differences in Gastroesophageal Junction and Gastric Adenocarcinoma in 2194 Patients: In Memory of Rebecca A. Carr, February 24, 1988-January 19, 2021Masaya Nakauchi, Elvira L Vos, Rebecca A Carr, et al.
Annals of Surgery|May 15, 2023
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal AdenocarcinomaAlexander J Byun, Rachel A Grosser, Jennie K Choe, et al.
The American Surgeon|February 1, 2021
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal AdenocarcinomaJames S Strong, Elvira L Vos, Caitlin A Mcintyre, et al.
JCO Precision Oncology|February 9, 2022
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived XenograftsRyan H Moy, Henry S Walch, Marissa Mattar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2026
Lung carcinoids with sustentacular cells and low keratin expression: A common yet under-recognized phenomenon with diagnostic and biological implicationsJonathan Willner, Rania G Aly, Prithviraj Solanki, et al.
The British Journal of Surgery|December 16, 2025
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort studyMasaya Nakauchi, Colin Court, Henry S Walch, et al.
The American Journal of Surgical Pathology|March 25, 2008
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?Jinru Shia, Laura H Tang, Martin R Weiser, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Human Pathology|March 18, 2008
Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significanceJinru Shia, David S Klimstra, James R Nitzkorski, et al.
Plos One|July 14, 2012
A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkersJordan M Winter, Laura H Tang, David S Klimstra, et al.
Nature Communications|March 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic targetTilman Werner, Johanna Thiery, Klara-Luisa Budau, et al.
Annals of Surgery|November 30, 2021
Distinct Differences in Gastroesophageal Junction and Gastric Adenocarcinoma in 2194 Patients: In Memory of Rebecca A. Carr, February 24, 1988-January 19, 2021Masaya Nakauchi, Elvira L Vos, Rebecca A Carr, et al.
Annals of Surgery|May 15, 2023
A Prospective Clinical Trial to Evaluate Mesothelin as a Biomarker for the Clinical Management of Patients With Esophageal AdenocarcinomaAlexander J Byun, Rachel A Grosser, Jennie K Choe, et al.
The American Surgeon|February 1, 2021
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal AdenocarcinomaJames S Strong, Elvira L Vos, Caitlin A Mcintyre, et al.
JCO Precision Oncology|February 9, 2022
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived XenograftsRyan H Moy, Henry S Walch, Marissa Mattar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2026
Lung carcinoids with sustentacular cells and low keratin expression: A common yet under-recognized phenomenon with diagnostic and biological implicationsJonathan Willner, Rania G Aly, Prithviraj Solanki, et al.
The British Journal of Surgery|December 16, 2025
Genomic and clinical parallels between US and Japanese gastric cancers: a propensity score-matched cohort studyMasaya Nakauchi, Colin Court, Henry S Walch, et al.
The American Journal of Surgical Pathology|March 25, 2008
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?Jinru Shia, Laura H Tang, Martin R Weiser, et al.
Pageof 18